期刊文献+

MMP-2和MMP-9在肺癌组织中的表达 被引量:1

Expression of MMP-2 and MMP-9 in Lung Cancer
下载PDF
导出
摘要 目的 :研究肺癌和正常肺组织中基质金属蛋白酶 2 (MMP 2 )和MMP 9的表达。方法 :采用免疫组织化学EnVision方法 ,对 71例肺癌标本和 31例正常肺组织检测MMP 2和MMP 9的表达。结果 :71例肺癌标本中 ,小细胞肺癌 (SCLC) 4例 ,MMP 2表达阳性 3例 (75 0 % ) ,MMP 9表达阳性 2例(5 0 0 % ) ;非小细胞肺癌 (NSCLC)有 6 7例 ,年龄 4 0岁以上 6 4例 ,MMP 2表达阳性 39例 ,阳性率 6 0 9%(39 6 4) ;MMP 9表达阳性 4 6例 ,阳性率 71 9% (4 6 6 4)。正常肺标本 31例 ,年龄 4 0岁以下MMP 2和MMP 9表达均为阴性 ,年龄在 4 0岁以上 2 6例 ,MMP 2阳性表达 9例 ,阳性率 34 6 % (9 2 6 ) ,MMP 9阳性表达 10例 ,阳性率 38 5 % (10 2 6 ) ;4 0岁以上NSCLC标本的MMP 2和MMP 9阳性表达与正常肺标本比较 ,差异均有显著意义。结论 :在NSCLC中高表达的MMP 2和MMP 9均是好的肿瘤标记物 ,但是 ,MMP 9阳性率比MMP 2更高 ,因此MMP 9的检测具有更大的临床意义。 Objective To study the expression of matrix metalloproteinase 2(MMP 2) and MMP 9 in lung cancer.Methods EnVision immunohistochemical technique was used to detect the expression of MMP 2 and MMP 9 in 71 cases of lung cancer and 31 cases of normal lung tissue.Results Of 71 patients,4 cases were small cell lung cancer,in which the positive immunoreactivity was demonstrated in 3(75 0%) for MMP 2 and in 2(50 0%) for MMP 9.Sixty seven cases were non small cell lung cancer(NSCLC) in which 64 cases were over 40 years,the positive immunoreactivity was demonstrated in 39(60 9%) for MMP 2 and in 46(71 9%) for MMP 9.Of 31 normal lung specimens,the positive immunoreactivities of MMP 2 and MMP 9 were all negative in cases of below 40 years.Of 26 cases of over 40 years the positive immunoreactivity was demonstrated in 9(34 6%) for MMP 2 and in 10(38 5%) for MMP 9.The expression of MMP 2 and MMP 9 in NSCLC was a significantly difference comparison with normal lung specimens.Conclusion MMP 2 and MMP 9 have high expression in NSCLC and they were good tumor markers.The positive rate of MMP 9 was higher than MMP 2,and therefore,detection of MMP 9 has more clinical significance.
出处 《肿瘤防治杂志》 2003年第9期920-922,共3页 China Journal of Cancer Prevention and Treatment
关键词 肺肿瘤/病理学 金属蛋白酶类/生物合成 免疫组织化学 lung neoplasms/pathology metalloproteinases/biosynthesis immunohistochemistry
  • 相关文献

参考文献2

二级参考文献3

共引文献49

同被引文献7

  • 1叶任高.内科学第5版[M].北京:人民卫生出版社,2000.798. 被引量:14
  • 2Kawamata H, Kameyama S,Kawai K,et al. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A[J]. Int J Cancer, 1995,63(4) :568-575. 被引量:1
  • 3Sier C F, Kubben F J, Ganesh S, et al. Tissue levels of matrix metalloproteinase MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma[J]. Br J Cancer, 1996,74(3) :413-417. 被引量:1
  • 4Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage[J]. Cancer Res,1993,53(21) :5289-5296. 被引量:1
  • 5Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer-TIMP-1 as a prognostic marker[J].Anticancer Res, 2000,20(2B) : 1311 - 1316. 被引量:1
  • 6Kleiner D E, Tunttila A, Tryggvason K, et al. Stability analysis of latent and active 72-kDa type Ⅳ collagenase:the role of tissue inhibitor of metalloproteinases- 2 ( TIMP - 2 ) [ J ]. Biochemistry, 1993,32(6) : 1583- 1592. 被引量:1
  • 7孙书明,周妍,胡志雄,金盈,潘俊杰,金复生.肺癌病人血清MMP-2和MMP-9的检测[J].中国临床医学,2003,10(5):637-638. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部